BioCentury
ARTICLE | Clinical News

Adolor begins Phase III

July 9, 2001 7:00 AM UTC

ADLR began a double-blind, placebo-controlled U.S. Phase III trial of ADL 8-2698 to treat opioid bowel dysfunction in about 160 patients taking opioid narcotics for chronic pain. The oral non-absorbed...